Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid

Clinical and Investigative Medicine

Volumn 19, Issue 3, 1996, Pages 171-178

  Rozen, Rima ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE MUTATION; HOMOCYSTINURIA; HUMAN; MOLECULAR GENETICS; NEURAL TUBE DEFECT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA, COMPLEMENTARY; FOLIC ACID; HOMOCYSTEINE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS;

EID: 0029931750     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. McCully KS: Vascular pathology of homocysteinemia. Am J Pathol 1969; 56: 111-128
2. Malinow MR: Homocysteine and arterial occlusive diseases. J Intern Med 1994; 236: 603-617
3. Boushey CJ, Beresford SAA, Omenn GS et al: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-1057
4. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM et al: Maternal hyperhomocysteinemia: A risk factor for neural-tube defects? Metabolism 1994; 43: 1475-1480
5. Mills JL, McPartin JM, Kirke PN et al: Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149-151
6. Rosenblatt DS: Inherited disorders of folate transport and metabolism. In Scriver CR, Beaudet al, Sly WS et al (eds): The Metabolic and Molecular Bases of Inherited Disease, 7th ed, McGraw-Hill, New York, 1995: 3111-3128
7. 6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 1994; 59: 1033-1039
8. Kang S-S, Wong PWK, Susmano A et al: Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545
9. Engbersen AMT, Franken DG, Boers GHJ et al: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Gen 1995; 56: 142-150
10. Goyette P, Sumner JS, Milos R et al: Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet 1994; 7: 195-200
11. Frosst P, Blom HJ, Milos R et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111-113
12. Goyette P, Frosst P, Rosenblatt DS et al: Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe MTHFR deficiency. Am J Hum Genet 1995; 56: 1052-1059
13. Kluijtmans LAJ, van den Heuvel LP, Boers GHJ et al: Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41
14. Jacques PF, Bostom AG, Williams RR et al: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9
15. Linder CC, Davisson MT: Mouse models for studying neural tube defects. Neurol News 1994; Sept
16. Rieder MJ: Prevention of neural tube defects with periconceptional folic acid. Clin Perinatol 1994; 21: 483-503
17. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P et al: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071
18. Whitehead AS, Gallagher P, Mills JL et al: A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-766